Your browser doesn't support javascript.
loading
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity.
Wang, Lindsey; Wang, William; Kaelber, David C; Xu, Rong; Berger, Nathan A.
Afiliação
  • Wang L; Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Wang W; Center for Science, Health, and Society, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Kaelber DC; Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences and the Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio.
  • Xu R; Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio.
  • Berger NA; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
JAMA Oncol ; 10(2): 256-258, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38060218
This cohort study compares glucagon-like peptide 1 receptor agonists (GLP-1RAs) with 7 non­GLP-1RA antidiabetics among drug-naive patients with type 2 diabetes.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos